Generics

Teva introduces generic Albenza

Teva's generic Albenza tablets are available in a dosage strength of 200 mg, in bottles of two tablets.
Lupin taps Sunil Makharia as interim CFO

Lupin has named an interim CFO while in the process of selecting a permanent candidate for the position.
Fresenius Kabi launches ready to administer Neostigmine methylsulfate injection

Fresenius Kabi is expanding its Simplist prefilled syringe portfolio with its fourth new product in a year.
Hikma launches generic Tracleer

Tracleer (bosentan) had a market value of $268 million in 2018.
Alembic gets FDA OK for generic Sinemet

Carbidopa and levodopa extended-release tablets had a market value of roughly $24 million for the 12 months ended December 2018.
AAM opposes changes to exclusivity in proposed bill

The Association for Accessible Medicines will oppose The Lower Health Care Costs Act without changes to the discussion draft, CEO Chip Davis told the Senate HELP Committee in a recent letter.
Novitium launches generic Revatio

Revatio for oral suspension, 10mg/ml, had a market value of about $200 million for the 12 months ended March 2019.
Upsher-Smith receives two DIANA awards, expands its HQ

Upsher-Smith received two Healthcare Distribution Alliance DIANA awards as it celebrated a nearly 300,000-sq.-ft. expansion of its headquarters.

AAM pushes to exclude generics from Chinese exports that will face tariffs